Abedat highlighted the importance of keeping pace with global developments in the pharmaceutical industry, enhancing research and development, employing advanced technology, and moving towards promising fields that include innovative and high-value products such as natural and herbal products and medical supplies for rapid detection and diagnosis, thereby supporting innovation, health and pharmaceutical security, and enhancing national capabilities and industries.
Abedat called for the establishment of a network between accredited research and development laboratories for drug analysis and development to enhance partnership and integration in the field of analytical and confirmatory methods for drugs developed by these laboratories, thereby supporting the pharmaceutical industry.
For her part, the Secretary-General of the Jordanian Union of Pharmaceutical Producers, Dr. Hanan Al-Sabboul, appreciated the institution's role as an enabler for the pharmaceutical industry sector to achieve its goals in the economic modernization vision in terms of creating job opportunities, increasing national exports, and enhancing the role of the national pharmaceutical industry in achieving pharmaceutical security in the Kingdom.
During the meeting, the CEO of the company, Dr. Abdul Hamid Sinqrut, and in the presence of the General Manager of the subsidiary companies of the main company, Mr. Taha Al-Kubaisi, the CEO's advisor, Mr. Mustafa Al-Kubaisi, the Director of the Drug Directorate at the institution, Dr. Rana Malakawi, and Dr. Rashid Salah from the Inspection Department and those concerned from both sides, affirmed the vital role of the institution in supporting the pharmaceutical industry and enhancing partnership between the industry and regulatory authorities, which are based on a common goal represented in providing safe, effective, and high-quality medicine, and developing a Jordanian pharmaceutical industry more capable of responding to market requirements and enhancing the presence of Jordanian medicine regionally and internationally.
He reviewed plans for growth and expansion, enhancing the company's presence in strategic markets, developing the product portfolio, and moving towards specialized manufacturing of injections and biological medicines, in addition to expanding partnerships and transferring technology to enhance the competitiveness of Jordanian medicine and its regional status.
During the visit, Abedat and the accompanying delegation toured the manufacturing facilities and reviewed the technical capabilities, accredited quality systems, and efforts to develop products and processes to enhance the ability to meet the needs of the local market and foreign markets.
The field visit came as part of a program of field visits to Jordanian pharmaceutical companies implemented by the institution in coordination with the Jordanian Union of Pharmaceutical Producers to explore opportunities for expansion and investment to achieve sustainable growth in this vital sector.
